Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 226-228, 2004; 10.1373/clinchem.2003.022962
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heesen, M.
Right arrow Articles by Blomeke, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heesen, M.
Right arrow Articles by Blomeke, B.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2004;50:226-228.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Rapid Genotyping for Tumor Necrosis Factor-{alpha} (TNF-{alpha}) -863C/A Promoter Polymorphism That Determines TNF-{alpha} Response

Michael Heesen1,a, Dagmar Kunz2, Martina Wessiepe3, Tom van der Poll4, Aeilko H. Zwinderman5 and Brunhilde Blomeke6

Departments of
1 Anesthesia,
4 Experimental Internal Medicine, and
5 Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Departments of
2 Clinical Chemistry and Pathobiochemistry,
3 Transfusion Medicine, and
6 Dermatology, University Hospital, Aachen, Germany

aaddress correspondence to this author at: Department of Anesthesia, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; fax 31-20-6979441, e-mail m.heesen@amc.uva.nl

The first 300 words of the full text of this article appear below.

Tumor necrosis factor-{alpha} (TNF-{alpha}) plays a central role in orchestrating the inflammatory response (1). Accordingly, blocking TNF-{alpha} activity has become a standard treatment of several inflammatory diseases (2)(3). TNF-{alpha} production shows high interindividual variations, which have been assigned mainly to inherited factors (4). Several genetic polymorphisms related to TNF-{alpha} synthesis have been detected in the TNF gene (5)(6). The -308 promoter polymorphism was found to affect TNF-{alpha} production by some authors (7) but not by others (8). Similar inconsistencies have been found for the association of this polymorphic site with susceptibility to and/or outcome of sepsis (8)(9). The NcoI polymorphism located within the first intron of the lymphotoxin A (LTA) gene was reported to be associated with TNF-{alpha} plasma concentrations (8). In a recent report, de Jong et al. (10) found no relationship between ex vivo TNF-{alpha} production on endotoxin stimulation of human whole blood and +489, -238, and -376 single-nucleotide polymorphisms or TNFa microsatellites of the TNF-{alpha} gene (10). Thus, the genetic factors determining the TNF-{alpha} response to infection are still poorly defined.

Recently, Skoog et al. (11) identified a C/A exchange at position -863 of the TNF-{alpha} gene promoter and found higher transcriptional activity of the C allele in reporter gene assays. This polymorphic site was found to be associated with thyroid-associated ophthalmopathy (12), Crohn disease(13), juvenile rheumatoid arthritis (14), and the lumbar spine area (15).

In the present study we sought to determine the association of the -863 TNF-{alpha} promoter polymorphism with the TNF-{alpha} production capacity of human blood cells. We describe a new real-time PCR assay with specific . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.